bZIP proteins of human gammaherpesviruses

Journal of General Virology

Volumn 84, Issue 8, 2003, Pages 1941-1949

  Sinclair, Alison J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; IMMEDIATE EARLY PROTEIN BZLF1; LEUCINE ZIPPER PROTEIN; RAP PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; B LYMPHOCYTE; CARCINOGENESIS; CELL CYCLE; CYTOLYSIS; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN HERPESVIRUS 8; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; VIRUS INFECTIVITY; VIRUS LATENCY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; REPRESSOR PROTEINS; TRANS-ACTIVATORS; VIRAL PROTEINS; VIRUS ACTIVATION;

DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 0043169617     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19112-0     Document Type: Review

References (76)

1. Adamson, A. L. & Kenney, S. C. (1998). Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Virology 251, 187-197.
2. Adamson, A. L. & Kenney, S. (1999). The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol 73, 6551-6558.
3. Adamson, A. L. & Kenney, S. (2001). Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75, 2388-2399.
4. Aho, S., Buisson, M., Pajunen, T., Ryoo, Y. W., Giot, J. F., Gruffat H., Sergeant, A. & Uitto, J. (2000). Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors. J Cell Biol 148, 1165-1176.
5. AuCoin, D. P., Colletti, K S., Xu, Y., Cei, S. A. & Pari, G. S. (2002). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication. J Virol 76, 7890-7896.
6. Baer, R., Bankier, A. T., Biggin, M. D. & 9 other authors (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
7. Baumann, M., Gires, O., Kolch, W., Mischak, H., Zeidler, R., Pich, D. & Hammerschmidt, W. (2000). The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1. Eur J Biochem 267, 3891-3901.
8. Bell, P., Lieberman, P. M. & Maul, G. G. (2000). Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74, 11800-11810.
9. Berk, A. J., Boyer, T. G., Kapanidis, A. N. & 7 other authors (1998). Mechanisms of viral activators. Cold Spring Harb Symp Quant Biol 63, 243-252.
10. Boshoff, C. & Chang, Y. (2001). Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med 52, 453-470.
11. Cayrol, C. & Flemington, E. K. (1995). Identification of cellular target genes of the Epstein-Barr virus transactivator Zta - activation of transforming growth-factor β-Igh3 (Tgf-β-Igh3) and Tgf-β-1. J Virol 69, 4206-4212.
12. 1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J Biol Chem 271, 31799-31802.
13. 1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J 15, 2748-2759.
14. Chen, C. J., Deng, Z., Kim, A. Y., Blobel, G. A. & Lieberman, P. M. (2001). Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol Cell Biol 21, 476-487.
15. Chi, T. & Carey, M. (1993). The ZEBRA activation domain: modular organization and mechanism of action. Mol Cell Biol 13, 7045-7055.
16. Chi, T. & Carey, M. (1996). Assembly of the isomerized TFIIA-TFIID-TATA ternary complex is necessary and sufficient for gene activation. Genes Dev 10, 2540-2550.
17. Chi, T., Lieberman, P., Ellwood, K. & Carey, M. (1995a). A general mechanism for transcriptional synergy by eukaryotic activators. Nature 377, 254-257.
18. Chi, T., Lieberman, P., Lehman, A. & Carey, M. (1995b). Mechanisms of transcriptional activation by Zebra, an Epstein-Barr virus protein. FASEB J 9, A1462.
19. Deng, Z., Chen, C. J., Zerby, D., Delecluse, H. J. & Lieberman, P. M. (2001). Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation. J Virol 75, 10334-10347.
20. Dreyfus, D. H., Nagasawa, M., Kelleher, C. A. & Gelfand, E. W. (2000). Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells. Blood 96, 625-634.
21. Ellwood, K., Huang, W., Johnson, R. & Carey, M. (1999). Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly. Mol Cell Biol 19, 2613-2623.
22. Everett, R. D. (2001). DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273.
23. Falquet, L., Pagni, M., Bucher, P., Hulo, N., Sigrist, C. J., Hofmann, K. & Bairoch, A. (2002). The PROSITE database, its status in 2002. Nucleic Acids Res 30, 235-238.
24. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. & Delecluse, H. J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19, 3080-3089.
25. Flemington, E. K. (2001). Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol 75, 4475-4481.
26. Flemington, E. K., Lytle, J. P., Cayrol, C., Borras, A. M. & Speck, S. H. (1994). DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities. Mol Cell Biol 14, 3041-3052.
27. Francis, A. L., Gradoville, L. & Miller, G. (1997). Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency. J Virol 71, 4543-4551.
28. Francis, A., Ragoczy, T., Gradoville, L., Heston, L., El-Guindy, A., Endo, Y. & Miller, G. (1999). Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator. J Virol 73, 3054-3061.
29. Gradoville, L., Gerlach, J., Grogan, E., Shedd, D., Nikiforow, S., Metroka, C. & Miller, G. (2000). Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J Virol 74, 6207-6212.
30. Gruffat, H., Portes-Sentis, S., Sergeant, A. & Manet, E. (1999). Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1. J Gen Virol 80, 557-561.
31. Gutsch, D. E., Holley-Guthrie, E. A., Zhang, Q., Stein, B., Blanar, M. A., Baldwin, A. S. & Kenney, S. C. (1994). The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-κB. Mol Cell Biol 14, 1939-1948.
32. Hicks, M. R., Balesaria, S., Medina-Palazon, C., Pandya, M. J., Woolfson, D. N. & Sinclair, A. J. (2001). Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. J Virol 75, 5381-5384.
33. Hong, Y., Holley-Guthrie, E. & Kenney, S. (1997). The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation. Virology 229, 36-48.
34. Hwang, S., Gwack, Y., Byun, H., Lim, C. & Choe, J. (2001). The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J Virol 75, 9509-9516.
35. Izumiya, Y., Lin, S. F., Ellison, T., Chen, L. Y., Izumiya, C., Luciw, P. & Kung, H. J. (2003). Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J Virol 77, 1441-1451.
36. Lieberman, P. (1994). Identification of functional targets of the Zta transcriptional activator by formation of stable preinitiation complex intermediates. Mol Cell Biol 14, 8365-8375.
37. Lieberman, P. M. & Berk A. J. (1991). The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev 5, 2441-2454.
38. Lieberman, P. M. & Berk, A. J. (1994). A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA-promoter DNA complex formation. Genes Dev 8, 995-1006.
39. Lieberman, P. M., Ozer, J. & Gursel, D. B. (1997). Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition. Mol Cell Biol 17, 6624-6632.
40. Lin, S. F., Robinson, D. R., Miller, G. & Kung, H. J. (1999). Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J Virol 73, 1909-1917.
41. Lu, J., Chen, S. Y., Chua, H. H., Liu, Y. S., Huang, Y. T., Chang, Y., Chen, J. Y., Sheen, T. S. & Tsai, C. H. (2000). Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. J Virol 74, 7391-7399.
42. Lukac, D. M., Renne, R., Kirshner, J. R. & Ganem, D. (1998). Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252, 304-312.
43. Lukac, D. M., Kirshner, J. R. & Ganem, D. (1999). Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73, 9348-9361.
44. Lupas, A., Van Dyke, M. & Stock, J. (1991). Predicting coiled-coils from protein sequences. Science 252, 1162-1164.
45. 2 and a mitotic block. J Virol 76, 10030-10037.
46. Mauser, A., Holley-Guthrie, E., Zanation, A., Yarborough, W., Kaufmann, W., Klingelhutz, A., Seaman, W. T. & Kenney, S. (2002b). The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol 76, 12543-12552.
47. Mauser, A., Saito, S., Appella, E., Anderson, C. W., Seaman, W. T. & Kenney, S. (2002c). The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol 76, 12503-12512.
48. Miller, G. (1989). The switch between EBV latency and replication. Yale J Biol Med 62, 205-213.
49. Morrison, T. E., Mauser, A., Wong, A., Ting, J. P. & Kenney, S. C. (2001). Inhibition of IFN-γ signaling by an Epstein-Barr virus immediate-early protein. Immunity 15, 787-799.
50. Ozer, J., Bolden, A. H. & Lieberman, P. M. (1996). Transcription factor IIA mutations show activator-specific defects and reveal a IIA function distinct from stimulation of TBP-DNA binding. J Biol Chem 271, 11182-11190.
51. Park, J., Seo, T., Hwang, S. M., Lee, D., Gwack, Y. & Choe, J. (2000). The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol 74, 11977-11982.
52. Pfitzner, E., Becker, P., Rolke, A. & Schule, R. (1995). Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions. Proc Natl Acad Sci U S A 92, 12265-12269.
53. Polson, A. G., Huang, L., Lukac, D. M., Blethrow, J. D., Morgan, D. O., Burlingame, A. L. & Ganem, D. (2001). Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J Virol 75, 3175-3184.
54. Portes-Sentis, S., Manet, E., Gourru, G., Sergeant, A. & Gruffat H. (2001). Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein. J Gen Virol 82, 507-512.
55. Ragoczy, T., Heston, L. & Miller, G. (1998). The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72, 7978-7984.
56. Rickinson, A. B. & Kieff, E. (1996). Epstein-Barr virus. In Fields Virology, 3rd edn, pp. 2397-2446. Edited by B. N. Fields, D. M Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
57. Rodriguez, A., Armstrong, M., Dwyer, D. & Flemington, E. (1999). Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J Virol 73, 9029-9038.
58. Rodriguez, A., Jung, E. J., Yin, Q., Cayrol, C. & Flemington, E. K. (2001). Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 284, 159-169.
59. Russo, J. J., Bohenzky, R. A., Chien, M.-C. & 8 other authors (1996). Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93, 14862-14867.
60. Schepers, A., Pich, D. & Hammerschmidt, W. (1996). Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220, 367-376.
61. Schwarzmann, F., Jager, M., Prang, N. & Wolf, H. (1998). The control of lytic replication of Epstein-Barr virus in B lymphocytes. Int J Mol Med 1, 137-142.
62. Seaman, W. T., Ye, D. S., Wang, R. X., Hale, E. E., Weisse, M. & Quinlivan, E. B. (1999). Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263, 436-449.
63. Sinclair, A. J. & Farrell, P. J. (1992). Epstein-Barr virus transcription factors. Cell Growth Differ 3, 557-563.
64. Sista, N. D., Pagano, J. S., Liao, W. & Kenney, S. (1993). Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc Natl Acad Sci U S A 90, 3894-3898.
65. Sista, N. D., Barry, C., Sampson, K. & Pagano, J. (1995). Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR α and RXR α. Nucleic Acids Res 23, 1729-1736.
66. Speck, S. H., Chatila, T. & Flemington, E. (1997). Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol 5, 399-405.
67. Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F. X. & Miller, G. (1998). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95, 10866-10871.
68. Sun, R., Lin, S. F., Staskus, K., Gradoville, L., Grogan, E., Haase, A. & Miller, G. (1999). Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73, 2232-2242.
69. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
70. Wang, S. E., Wu, F. Y., Fujimuro, M., Zong, J., Hayward, S. D. & Hayward, G. S. (2003). Role of CAAT/enhancer-binding protein α (C/EBP α) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP. J Virol 77, 600-623.
71. Wu, F. Y., Ahn, J. H., Alcendor, D. J., Jang, W. J., Xiao, J., Hayward, S. D. & Hayward, G. S. (2001). Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J Virol 75, 1487-1506.
72. 1 cell cycle arrest through CCAAT/enhancer-binding protein-α. Proc Natl Acad Sci U S A 99, 10683-10688.
73. 1 cell cycle arrest during the Epstein-Barr virus lytic cycle. J Virol 77, 1481-1500.
74. Zerby, D., Chen, C. J., Poon, E., Lee, D., Shiekhattar, R. & Lieberman, P. M. (1999). The amino-terminal C/H1 domain of CREB binding protein mediates Zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol 19, 1617-1626.
75. Zhang, Q., Gutsch, D. & Kenney, S. (1994). Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol 14, 1929-1938.
76. Zhu, F. X., Cusano, T. & Yuan, Y. (1999). Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 73, 5556-5567.